Gilead Sciences to Acquire Arcellx for $7.8 Billion
Gilead Sciences, Inc. (GILD) entered a merger agreement on February 23, 2026, to acquire Arcellx, Inc. (ACLX) for $7.8 billion. Deal Structure: A wholly-owned subsidiary of Gilead…
Written byAsif SuriaSource: InsideArbitrage
Gilead Sciences, Inc. (GILD) entered a merger agreement on February 23, 2026, to acquire Arcellx, Inc. (ACLX) for $7.8 billion. Deal Structure: A wholly-owned subsidiary of Gilead will commence a tender offer to acquire all of the outstanding shares of Arcellx’s common stock for an offer price of $115 per share in cash, plus one